Warning letters raise patient safety concerns for Fentora
October 22nd 2007In response to a number of deaths and serious adverse events reported by patients taking Fentora, warning letters were sent to health care professionals. According to Cephalon, Inc., the deaths primarily occurred as a result of improper patient selection, improper dosing, and/or improper product substitution.
N.J. R.Ph.s urge action against Medicaid generic reimbursement rule
October 22nd 2007New Jersey pharmacists gathered recently to draw attention to and protest against what they hold to be a flawed reimbursement program for Medicaid generic prescription drug reimbursement contained in the Deficit Reduction Act (DRA) of 2005.